The collaborative prowess of ROELMI HPC's renowned cosmetic expertise and the profound probiotics knowledge from its sister company, SynBalance, has given rise to the remarkable EquiBiotics® line. This innovative ingredient range signifies a fresh perspective on postbiotic ingredients, paving the way for groundbreaking solutions in the realm of personal care.
A specialized soft process enables the deactivation of bacteria while preserving the integrity of the bacterial wall responsible for co-aggregation. Furthermore, this process facilitates the retention of specific bacterial benefits.
Designed with precision biofermentation, EquiBiotics® line strategically addresses specific conditions, placing a special emphasis on intimate care and sensitive skin.
L. acidophilus PBS066 and L. rhamnosus LRH020 are the precursors of two high-value postbiotic cosmetic ingredients (EquiBiotics® LA and EquiBiotics® LRh), capable of targeting specific requirements for certain cosmetic applications, thanks to their properties including resistance, and adaptability. They are proprietary science-backed probiotics bacteria owned by Synbalance and, they have been primarily involved in the development and manufacturing of probiotics intended for use in food supplements.
EquiBiotics® LA emerges as the perfect companion for baby care, showcasing proven anti-inflammatory properties and exceptional moisturizing capabilities. It can be an ideal solution for soothing and calming skin redness. Its efficacy extends beyond addressing typical signs of sensitive skin, as its influence on the skin microbiota enables the prevention of potential stressors that could aggravate sensitive and reactive skin conditions.
Recently, an additional clinical study has been conducted on infants/children aged between 3 months and 36 months old and results showed the ability of EquiBiotics® LA in reducing skin erythema in 77,3% of the subjects after 7 days of application.
On the other hand, EquiBiotics® LRh takes center stage in intimate care concerns and skin well-being, with efficacy tests demonstrating its ability to inhibit pathogens proliferation on the vaginal epithelium. For both applications, the ingredient is supported by an extensive dossier demonstrating its benefits through in vitro and ex vivo studies. Recently, an additional clinical study has been conducted on menopausal women to assess the positive properties in the intimate areas. Results revealed that after 28 days of application, the active biotech ingredient can help rebalance the microbiota, leading to a state of eubiosis. Studies have also shown that within just one hour, the ingredient increases hydration in 95% of the subjects examined, while also lowering the pH of intimate areas, thereby reducing the likelihood of imbalances. Further research has demonstrated improvements in additional parameters, such as a reduction in TEWL, decreased skin redness, and enhanced elasticity, positioning Equibiotics® LRh as a valuable ally for healthier, more balanced skin.
www.roelmihpc.com – info@roelmihpc.com
LinkedIn – Instagram – Youtube – Facebook
